Arable claimed that its Perform platform allows sponsors or CROs to manage the planning and implementation of multiple trials simultaneously.
Perform also provides large Sites with the ability to manage their service delivery to multiple CROs or Sponsors. With Perform’s proprietary dashboard, stakeholders and managers are able to view real-time status of trials down to the site or subject visit, Arable said.
Arable CEO Ary Sarkar said that their new Perform platform allows them to offer their clients immediate access to clinical trial software with the shortest ‘Go Live’ time in the industry and at a reasonable cost.
"At Arable, we combine our knowledge of the clinical trial space with our technology partnerships to offer our clients a range of services from trial planning and implementation through regulatory submittal," Sarkar said.